InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Reilly Dennis, Chief Financial Officer. Director active across 1 companies, notably Agile Therapeutics INC. Aggregated, 6 filings have been recorded. Total volume traded: €136k. The latest transaction was filed on 27 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
58,824 shares
Common Stock
SEC:0001104659-21-126014·
Ideal exit: 10 Jul 2022 (T+270)
58,824 shares
Common Stock
SEC:0001104659-21-126014:0·
Ideal exit: 10 Jul 2022 (T+270)
€45,79650,000 shares@ €0.915967.3% of flow
Common Stock
SEC:0001104659-21-097152·
Ideal exit: 23 Apr 2022 (T+270)
€45,79650,000 shares@ €0.915933.7% of flow
Common Stock
SEC:0001104659-21-097152:0·
Ideal exit: 23 Apr 2022 (T+270)
€22,23220,000 shares@ €1.111632.7% of flow
Common Stock
SEC:0001104659-21-065161·
Ideal exit: 5 Feb 2022 (T+270)
€22,23220,000 shares@ €1.111616.3% of flow
Common Stock
SEC:0001104659-21-065161:0·
Ideal exit: 5 Feb 2022 (T+270)
6 of 6 declarations
About Reilly Dennis
Dennis Reilly is the Chief Financial Officer at Agile Therapeutics Inc. He oversees financial management, budgeting, and investment strategy for the company. Dennis plays a key role in optimizing financial performance and regulatory compliance.
